1. Home
  2. SBSW vs GKOS Comparison

SBSW vs GKOS Comparison

Compare SBSW & GKOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SBSW
  • GKOS
  • Stock Information
  • Founded
  • SBSW 2013
  • GKOS 1998
  • Country
  • SBSW South Africa
  • GKOS United States
  • Employees
  • SBSW N/A
  • GKOS N/A
  • Industry
  • SBSW Precious Metals
  • GKOS Medical/Dental Instruments
  • Sector
  • SBSW Basic Materials
  • GKOS Health Care
  • Exchange
  • SBSW Nasdaq
  • GKOS Nasdaq
  • Market Cap
  • SBSW 5.3B
  • GKOS 5.8B
  • IPO Year
  • SBSW N/A
  • GKOS 2015
  • Fundamental
  • Price
  • SBSW $7.57
  • GKOS $95.82
  • Analyst Decision
  • SBSW Hold
  • GKOS Strong Buy
  • Analyst Count
  • SBSW 3
  • GKOS 12
  • Target Price
  • SBSW $4.73
  • GKOS $131.17
  • AVG Volume (30 Days)
  • SBSW 7.1M
  • GKOS 795.2K
  • Earning Date
  • SBSW 08-28-2025
  • GKOS 07-30-2025
  • Dividend Yield
  • SBSW N/A
  • GKOS N/A
  • EPS Growth
  • SBSW N/A
  • GKOS N/A
  • EPS
  • SBSW N/A
  • GKOS N/A
  • Revenue
  • SBSW $6,290,132,787.00
  • GKOS $432,953,000.00
  • Revenue This Year
  • SBSW $7.63
  • GKOS $28.79
  • Revenue Next Year
  • SBSW $5.23
  • GKOS $25.65
  • P/E Ratio
  • SBSW N/A
  • GKOS N/A
  • Revenue Growth
  • SBSW 3.11
  • GKOS 26.70
  • 52 Week Low
  • SBSW $3.05
  • GKOS $77.10
  • 52 Week High
  • SBSW $9.85
  • GKOS $163.71
  • Technical
  • Relative Strength Index (RSI)
  • SBSW 39.01
  • GKOS 57.21
  • Support Level
  • SBSW $7.10
  • GKOS $91.43
  • Resistance Level
  • SBSW $8.50
  • GKOS $94.71
  • Average True Range (ATR)
  • SBSW 0.24
  • GKOS 2.66
  • MACD
  • SBSW -0.12
  • GKOS 1.06
  • Stochastic Oscillator
  • SBSW 27.49
  • GKOS 89.34

About SBSW D/B/A Sibanye-Stillwater Limited ADS

Sibanye Stillwater Ltd is a South African mining and metals processing group with a diverse portfolio of operations, projects, and investments across five continents. The Group is also one of the foremost recyclers of PGM autocatalysts and has interests in mine tailings retreatment operations. It is a producer of platinum, palladium, and rhodium and is a top-tier gold producer. It also produces and refines iridium and ruthenium, nickel, chrome, copper, and cobalt. Its products are Gold, Nickel, Zinc, Chrome, PGMs, and other.

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. It has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

Share on Social Networks: